Prostate Cancer...Don't Let It Rob You Of Your Life
Prostate Cancer is more common than you think
Prostate cancer is the fourth leading cause of male cancer deaths in Hong Kong. In 2014, a total of 398 men died from this cancer, accounting for 4.8% of male cancer deaths. The crude death rate of prostate cancer was 11.9 per 100000 male population. The age-standardised death rate of prostate cancer was 5.8 per 100000 standard population.
In the US, Other than skin cancer, prostate cancer is the second commonest cancer in men.
Risk of prostate cancer
About 1 man in 7 will be diagnosed with prostate cancer during his lifetime.
Prostate cancer develops mainly in older men. About 6 cases in 10 are diagnosed in men aged 65 or older, and it is rare before age 40. The average age at the time of diagnosis is about 66.
Prostate cancer is rare in men younger than 40, but the chance of having prostate cancer rises rapidly after age 50. About 6 in 10 cases of prostate cancer are found in men older than 65.
Prostate cancer occurs more often in Africans and blacks than white or Asian men.
Prostate cancer is most common in North America, northwestern Europe, Australia, and on Caribbean islands. It is less common in Asia, Africa, Central America, and South America.
Prostate cancer seems to run in some families, which suggests that in some cases there may be an inherited or genetic factor.
Having a father or brother with prostate cancer more than doubles a man’s risk of developing this disease. The risk is much higher for men with several affected relatives, particularly if their relatives were young when the cancer was found.
Men who eat a lot of red meat or high-fat dairy products appear to have a slightly higher chance of getting prostate cancer. These men also tend to eat fewer fruits and vegetables.
Obesity increase the risk of advanced prostate cancer.
Most studies have not found a link between smoking and getting prostate cancer. Some research has linked smoking to a possible small increased the risk of dying from prostate cancer.
Advances In Prostate Cancer Screening
Prostate cancer can often be found early by testing for prostate-specific antigen (PSA) levels in a man’s blood. Another way to find prostate cancer early is the digital rectal exam (DRE), in which the doctor puts a gloved, lubricated finger into the rectum to feel the prostate gland.
However, neither the PSA test nor the DRE is 100% accurate. These tests can sometimes have abnormal results even when a man does not have cancer (known as a false-positive result), or normal results even when a man does have cancer (known as a false-negative result). False-positive results can lead some men to have a prostate biopsy when they don’t have cancer.
The Prostate Health Index (Phi) Test
The Prostate Health Index (PHI) is a new formula that combines all three forms (total PSA, free PSA and p2PSA) into a single score that can be used to aid in clinical decision-making. PHI is a simple and inexpensive blood test that is indicated for use for men over 50 years of age with a PSA level between 2-10 ng/mL with a digital rectal exam that is non-suspicious for cancer. Because phi is three times better at detecting prostate cancer, having a phi test before a prostate biopsy will give your doctor greater confidence that a biopsy is, or isn’t, the best choice for you.
At Neo-Health, we provide the latest innovative tests to help detect prostate cancer early and accurately. Start screening early for prostate cancer especially if you have the above risk factors for prostate cancer. Enquire with our friendly team of doctors to see which screening tests are best for you!